SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-017477
Filing Date
2018-07-26
Accepted
2018-07-25 21:07:33
Documents
5
Period of Report
2018-07-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 2018.07_UNDERWRITING AG reta-8k_20180725.htm 8-K 35759
2 EX-1.1 UNDERWRITING AG reta-ex11_6.htm EX-1.1 219188
3 EX-5.1 OPINION VE reta-ex51_30.htm EX-5.1 17749
4 GRAPHIC g1ylrg0wlo13000001.jpg GRAPHIC 3680
5 GRAPHIC g1ylrg0wlo13000002.jpg GRAPHIC 4837
  Complete submission text file 0001564590-18-017477.txt   285840
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37785 | Film No.: 18969901
SIC: 2834 Pharmaceutical Preparations